P/E ratio for VolitionRx (VNRX)
P/E ratio as of May 2024 (TTM): -1.43
According to VolitionRx's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.42857. At the end of 2022 the company had a P/E ratio of -4.42.
P/E ratio history for VolitionRx from 2012 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -4.42 | -29.65% |
| 2021 | -6.28 | -25.74% |
| 2020 | -8.46 | -26.85% |
| 2019 | -11.6 | 264.07% |
| 2018 | -3.18 | -39.52% |
| 2017 | -5.25 | -39.11% |
| 2016 | -8.62 | 1.56% |
| 2015 | -8.49 | 32.8% |
| 2014 | -6.39 | -12.35% |
| 2013 | -7.29 | 16.28% |
| 2012 | -6.27 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.